Phase 1 Gestational Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy

Gestational Diabetes Mellitus (GDM)Postpartum WomenUncomplicated Pregnancy

Anna Stanhewicz, PhD84 enrolled1 locationNCT06911372

Recruiting

Phase 1Phase 2

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment

Gestational Trophoblastic Neoplasias (GTN)

Hospices Civils de Lyon26 enrolled9 locationsNCT04396223

Terminated

Phase 1

Combination Gefitinib and Methotrexate for the Treatment of Persistent Gestational Trophoblastic Disease: A Phase I Clinical Trial

Persistent Gestational Trophoblastic Disease

Miss Orla McNally, Director Gynaecological Oncology & Dysplasia12 enrolled1 locationACTRN12611000104954